Anti-depressant drug from Wockhardt

By Our Staff Correspondent

MUMBAI, AUG. 6. Wockhardt Ltd. has launched Venlafaxine Capsules, an anti-depressant drug, under the brand name of Flavix-XR. Flavix-XR is a Novel Drug Delivery System (NDDS) product with a once-a-day dose for a 24-hour action.

Mr. Habil F Khorakiwala, chairman, Wockhardt Ltd. said, ``We are focussing on some of the lifestyle segments such as depression, diabetes, heart diseases and psychological illnesses.'' Venlafaxine is a well-accepted product globally with sales of over $1 billion.

Wockhardt now ranks second to Sun Pharmaceuticals in the domestic anti-depressant market which is pegged at Rs. 136 crores. The company is currently manufacturing Flavix-XR at its Gujarat facility.

Wockhardt has three products apart from Flavix-XR in the anti- depressant market, namely, Tryptomar-XR, Libotrip and Platin.

Send this article to Friends by E-Mail

Section  : Business
Previous : Cipla launches new AIDS drug
Next     : Metlife India gets IRDA nod